Terms, Conditions and Challenges for the Protection of Pharmaceutical Patents in Legal Systems in the Event of Accession to the World Trade Organization

Authors

  • Somayeh Rahmani, Islamic Azad University, Tehran, Iran Author

DOI:

https://doi.org/10.61841/cd7xq877

Keywords:

protection of pharmaceutical patents,, WTO,, TRIPS Agreement, Doha Declaration on public health.

Abstract

Today, various diseases such as AIDS, malaria and others are on the rise in human societies, despite the relative expansion of public health around the world. Therefore, the pharmaceutical industry is among the most important industries that need to be supported so that inventors of new drugs are motivated enough to produce more effective drugs. On the other hand, the undeniable benefits of protecting pharmaceutical patents for developed and least developed countries are considered as a serious threat that may endanger the public health of these societies. Under such circumstances, it must be determined which of the two principles (public health as a basic right of every human or protection of pharmaceutical patents as exclusive rights of its owners) should be preferred and prioritized? One of the most important issues that is directly and indirectly focused in the World Trade Organization is the public health, especially the drug trade and the protection of pharmaceutical patents. The organization has consistently protected the exclusive rights of pharmaceutical patentees to maintain a balance between public health and freedom of access to medicines. Each of the legal systems that seek to access to the WTO may face problems because of these two issues. This study was conducted aimed at examining the conditions and challenges for the protection of pharmaceutical patents in legal systems in the event of accession to the WTO.

 

Downloads

Download data is not yet available.

References

1. Amir Arjomand, Ardeshir; Habibi Mojandeh, Mohammad (2005). The Status of Intellectual Property Rights in International Human Rights Law, Nameh-Ye-Mofid, No. 52.

2. Borhani, Mohsen; Abouzari, Mehrnoosh (2017). The Right to Medications along with Supporting Drug Innovations, Judiciary Law Journal.

3. Parvin, Mohammad Reza (2009). Les brevets pharmaceutiques et ses problématiques, Journal of Medical Law, Vol. 3, No. 8.

4. Pilvar, Rahim; Hosseini Balouchi, Milad (2018). Facilitating Access to Medicine for Developing and Least Developed Countries by WTO, with Emphasis on Latest Developments in TRIPS Agreement, Journal of Medical Law, Vol. 12, No. 45.

5. Habiba, Saeed (2004). Iranian Patent System After Accepting Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS), Law and Political Science, University of Tehran, No. 66.

6. Habiba, Saeed (2007). New Challenges to Intellectual Property Law, Journal of Law, Law and Political Science, Vol. 37, No. 4.

7. Habiba, Saeed; Moein Eslam, Mohammad (2018). Globalization of Intellectual Property Law and the Challenge of Development and Public Health, Journal of Medical Law, Vol. 12, No. 44.

8. Sheikhi, Maryam (2016). Challenges of Intellectual Property Rights in the Field of Health, Social Welfare Quarterly, Vol. 5, No. 20, pp. 68-82.

9. Sadeghi, Mahmoud; Khakpour, Mansour (2007). Grounds for Granting Compulsory Licensing of Intellectual Property Rights, Tarbiat Modares University Quarterly Journal of Humanities, No. 4.

10. Abbasi, Mahmoud; Khakpour, Mansour; Foroughi, Mostafa (2012). Legal Protection of Medicinal Inventions in International Documents and Conventions, Journal of Medical Law, No. 2.

11. Azizi Moradpour, Hamid (2012). Reflections on Article 30 of the TRIPS Agreement and Lessons from WTO Dispute Settlement Body Practice, Journal of Private Law Research, Vol. 1, No. 1.

12. Fathi Zadeh, Amir Houshang (2003). Investigating Patent in the Regulations of the Agreement on Trade Related Aspects of Intellectual Property Rights: A Case Study of the Patent of a Pharmaceutical Product, Journal of Business Studies, No. 3.

13. Monfared, Mahvash (2015). Conflict of Pharmaceutical Patents and Protection of Human Rights; Legal Interpretation of Article 27 of TRIPS Agreement, Journal of Medical Law.

14. Molla Ebrahimi, Emad; Arfania, Behshid (2017). Investigating the Conflict of Patents and Access to Health with Emphasis on the Role of the WTO, 1st National Conference on Social Sciences, Education, Psychology and Social Security.

15. Mir Shamsi, Mohammad Hadi (2015). TRIPS Agreement and its Role in Development of International Protection of Intellectual Property, Quarterly Journal of Religion and Law, No. 7.

16. Niavrani, Saber; Javid, Ehsan (2016). Access to Essential Medicines in the Framework of TRIPS Agreement and the Challenge of Protecting International Human Rights to Health, International Law Journal

Downloads

Published

30.06.2020

How to Cite

Rahmani, , S. (2020). Terms, Conditions and Challenges for the Protection of Pharmaceutical Patents in Legal Systems in the Event of Accession to the World Trade Organization. International Journal of Psychosocial Rehabilitation, 24(4), 8228-8238. https://doi.org/10.61841/cd7xq877